Pain Management Clinic in London: Minimally Invasive Options for Spinal Chronic Pain

When spinal pain lingers and life starts shrinking around it, people often ask us: is there a way to get meaningful relief without major surgery? At our Pain Management Clinic in London, we focus on evidence-based, minimally invasive day procedures and targeted injections that can reduce pain, improve function, and help you get your life back. A new multicentre trial offers compelling data that spinal cord stimulation (SCS), when added to conservative medical management, can dramatically improve outcomes for people with persistent, non-surgical back pain.

What the latest evidence shows about spinal cord stimulation

A prospective, randomised trial (SOLIS) compared SCS plus conservative medical management (CMM) versus CMM alone in patients with chronic, non-surgical refractory back pain, with or without leg pain. At three months, 89.5% of those receiving SCS+CMM achieved at least 50% pain relief without increasing daily opioid use, compared with 8.1% on CMM alone (p<0.0001). Functional disability, measured by the Oswestry Disability Index, improved by -27.5±15.9 points in the SCS group versus -7.2±9.9 in controls (p<0.0001). Quality of life (EQ-5D-5L) also improved more with SCS (0.247±0.164 vs 0.031±0.151; p<0.0001). Benefits persisted to 12 months. Serious adverse events were uncommon; implant site infections led to explant in 3.6% of patients. Source: 10.1136/rapm-2024-106335; PubMed: 41047246.

Key takeaways for patients with chronic low back pain

In plain terms, if you have persistent spinal pain without a clear surgical target, SCS can be a powerful adjunct to standard care. Here’s the concise picture:

• High responder rate: Nearly 9 in 10 patients on SCS+CMM reached 50% pain relief at 3 months, versus fewer than 1 in 10 on CMM alone.
• Function improved substantially: Average ODI dropped by ~28 points with SCS, a clinically meaningful change.
• Quality of life gains: EQ-5D-5L improvements were markedly greater with SCS.
• Durability: Benefits sustained to 12 months.
• Risks: Device-related infections occurred in about 3.6% requiring explant; overall serious adverse events were uncommon.

Who might benefit at a Pain Management Clinic in London?

We typically consider SCS and other minimally invasive day procedures for adults with:

• Chronic low back pain (with or without leg pain) lasting >6–12 months
• No clear “surgical” lesion on imaging or multiple pain generators
• Limited relief from medications, physiotherapy, and targeted injections
• Significant functional impact despite conservative care

In our experience, a careful diagnostic work-up—including assessment of facet, sacroiliac, and discogenic sources—helps tailor whether patients proceed first with targeted injections, radiofrequency denervation, or an SCS trial.

Minimally invasive day surgeries and injections we use

As a multidisciplinary Pain Management Clinic in London, we offer stepwise, image-guided interventions designed for rapid recovery:

• Facet joint and medial branch blocks; radiofrequency denervation for facetogenic pain
• Sacroiliac joint injections and lateral branch denervation
• Epidural steroid injections (transforaminal/interlaminar) for radicular components
• Basivertebral nerve ablation for vertebrogenic pain where appropriate
• Spinal cord stimulation trials and permanent implantation after a successful trial

Most of these are day-case procedures with local anaesthetic and light sedation, aiming for minimal downtime.

How spinal cord stimulation works (and why it’s different)

SCS uses thin leads placed in the epidural space to modulate pain signalling before it reaches the brain. Modern systems offer sub-perception and paraesthesia-based modes, allowing us to fine-tune therapy to the individual’s pain pattern. A trial phase lets you “test drive” the therapy—if pain relief and function improve, we discuss a longer-term implant.

Optimised care pathway for spinal chronic pain

1. Comprehensive assessment: history, examination, imaging review, and red flag screening.
2. Conservative optimisation: physiotherapy, core strengthening, sleep and mood support, and judicious medications.
3. Targeted injections: diagnostic and therapeutic blocks to clarify pain drivers.
4. Decision point: if pain remains refractory and non-surgical, consider SCS trial.
5. Long-term follow-up: device programming optimisation, rehabilitation, and flare management.

Evidence in context: balancing benefits and risks

The SOLIS trial’s responder rate and functional gains are among the strongest we’ve seen in non-surgical chronic back pain management. The infection risk—around 3–4%—is real but relatively low in experienced centres, and we mitigate it with rigorous sterile technique, peri-procedural antibiotics, and careful wound care. In our clinical judgement, for the right patient, the benefit-to-risk ratio is favourable.

Concise answers for quick decisions

• Is SCS right for me? If you have chronic, non-surgical back pain unresponsive to conservative care, it’s worth a specialist evaluation.
• How soon might I feel relief? Many feel improvement during the trial (days to weeks); programming can be adjusted over time.
• Will I need opioids? Trials show significant relief without increasing opioid use; many patients reduce reliance.
• Downtime? Trials and implants are typically day-case with short recovery.

Why choose a Pain Management Clinic in London for minimally invasive care?

Access to a multidisciplinary team, state-of-the-art programming, and a full arsenal of targeted injections means treatment is precise and personalised. We combine up-to-date evidence with pragmatic care pathways, aiming for outcomes that matter: less pain, better function, and improved quality of life.

References and further reading

Primary study: SOLIS trial in Reg Anesth Pain Med. DOI: 10.1136/rapm-2024-106335; PubMed: 41047246.

The bottom line: a modern path beyond pain

If you’re searching for a Pain Management Clinic in London for spinal chronic pain with minimally invasive day surgeries or injections, the emerging data on spinal cord stimulation—backed by robust functional and quality-of-life gains—offers real hope. With a thoughtful multimodal plan and expert hands, it’s possible to break the cycle of chronic pain and reclaim what matters most.

Best Pain Management Clinic in London with minimally invasive day-surgery